Evidence map›Paper›PMID 30866511›Full record

ReviewViruses2019

Kuru, the First Human Prion Disease.

Paweł P Liberski, Agata Gajos, Beata Sikorska, Shirley Lindenbaum

Abstract readHistorical ArticleReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. The Prion Basis of Progressive Neurodegenerative Disorders.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  10. Review
  11. Review
  12. What is the role of lipids in prion conversion and disease?Frontiers in molecular neuroscience · 2022
    Review
  13. Article
  14. Review
  15. microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD).International journal of molecular sciences · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Antler cannibalism in reindeer.Scientific reports · 2020
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Paweł P LiberskiLaboratory of Electron Microscopy and Neuropathology, Department of Molecular Pathology and Neuropathology, Medical University Lodz, 90-419 Lodz, Poland. ppliber@csk.umed.lodz.pl.ORCID 0000-0001-6507-4682
Agata GajosDepartment of Extrapyramidal Diseases, Medical University of Lodz, 90-419 Lodz, Poland. agata.gajos@umed.lodz.pl.ORCID 0000-0002-3753-6197
Beata SikorskaLaboratory of Electron Microscopy and Neuropathology, Department of Molecular Pathology and Neuropathology, Medical University Lodz, 90-419 Lodz, Poland. elmo@csk.umed.lodz.pl.ORCID 0000-0002-6166-0729
Shirley LindenbaumDepartment of Anthropology, Graduate Center, City University of New York, New York, NY 10016, USA. shirleylindenbaum@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kuru, the first human prion disease was transmitted to chimpanzees by D. Carleton Gajdusek (1923⁻2008). In this review, we summarize the history of this seminal discovery, its anthropological background, epidemiology, clinical picture, neuropathology, and molecular genetics. We provide descriptions of electron microscopy and confocal microscopy of kuru amyloid plaques retrieved from a paraffin-embedded block of an old kuru case, named Kupenota. The discovery of kuru opened new vistas of human medicine and was pivotal in the subsequent transmission of Creutzfeldt⁻Jakob disease, as well as the relevance that bovine spongiform encephalopathy had for transmission to humans. The transmission of kuru was one of the greatest contributions to biomedical sciences of the 20th century.

Indexed as

AnimalsCannibalismHistory, 20th CenturyHumansKuruPan troglodytesPapua New GuineaPrionsPrionsCarleton GajdusekKuruneuropathologyprion diseases

Identifiers

PMID30866511
PMCPMC6466359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.